Tolnaftate

Tolnaftate 1 percent

Antifungal

• clinically proven to cure most athlete's foot (tinea pedis) and ringworm (tinea corporis)
• helps prevent most athlete's foot from recurring when used daily
• effectively soothes and relieves symptoms of athlete's foot, including itching, burning and cracking
  

For external use only

When using this product avoid contact with the eyes

• irritation occurs
• there is no improvement within 4 weeks
  

on children under 2 years of age except under the advice and supervision of a doctor.

If swallowed, get medical help or contact a Poison Control Center right away.

• wash affected area and dry thoroughly
• apply a thin layer over affected area twice daily (morning and night)
• supervise children in the use of this product
• for athlete's foot, pay special attentional to spaces between the toes, wear well-fitting, ventilated shoes and change shoes and socks at least once daily
• use daily for 4 weeks; if condition persists longer ask a doctor
• to prevent athlete's foot, apply once or twice daily (morning and night)
• this product is not effective on the scalp or nails
  

store between 2 degrees and 30 degrees Celsius (36 degrees and 86 degrees Fahrenheit)

carbomer 940, cetyl alcohol, chlorocresol, dibasic sodium phosphate hydrate, glycerin, glyceryl monostearate, light liquid paraffin, purified water, and stearic acid

NDC NO. 53210-1001-0
Tolnafate 1 percent
Cream USP 1 percent Antifungal

Relieves Itching and Burning

Cures and Prevents Athlete's Foot

Prevents and Relieves Itching and Redness

Anti-Itch Cream for Skin Irritations

Compare to Tinactin (R) active ingredient
This product is n ot manufactured or distributed by Schering-Plough Healthcare Products, Inc. owner of the registered Trademark Tinactin

Maximum Strength

Net 1 oz(28.3g)

Exclusively distributed by:
Morales Distributors, Inc
Mayaguez, P.R. 00682

Made in Korea

[Image in the official label — see DailyMed source]

[Image in the official label — see DailyMed source]

[Image in the official label — see DailyMed source]